Currently there are no disease-modifying treatments for Parkinson’s disease dementia (PDD), a condition linked to aggregation of the protein α-synuclein in subcortical and cortical brain areas. One of the leading genetic risk factors for Parkinson's disease is being a carrier in the gene for β-Glucocerebrosidase (GCase; gene name GBA1). Studies in cell culture and animal models have shown that raising the levels of GCase can decrease levels of α-synuclein. Ambroxol is a pharmacological chaperone for GCase and is able to raise the levels of GCase and could therefore be a disease-modifying treatment for PDD. The aims of this trial are to determine if Ambroxol is safe and well-tolerated by individuals with PDD and if Ambroxol affects cognitive, biochemical, and neuroimaging measures. This is a phase II, single-centre, double-blind, randomized placebo-controlled trial involving 75 individuals with mild to moderate PDD. Participants will be randomized into Ambroxol high-dose (1050 mg/day), low-dose (525 mg/day), or placebo treatment arms. Assessments will be undertaken at baseline, 6-months, and 12-months follow up times. Primary outcome measures will be the Alzheimer’s disease Assessment Scale-cognitive subscale (ADAS-Cog) and the ADCS Clinician’s Global Impression of Change (CGIC). Secondary measures will include the Parkinson’s disease Cognitive Rating Scale, Clinical Dementia Rating, Trail Making Test, Stroop Test, Unified Parkinson’s disease Rating Scale, Purdue Pegboard, Timed Up and Go, and gait kinematics. Markers of neurodegeneration will include MRI and CSF measures. Pharmacokinetics and pharmacodynamics of Ambroxol will be examined through plasma levels during dose titration phase and evaluation of GCase activity in lymphocytes. If found effective and safe, Ambroxol will be one of the first disease-modifying treatments for PDD. ClinicalTrials.gov NCT02914366, 26 Sep 2016/retrospectively registered.
1 November 2009 in Parkinsonism & Related Disorders
Hand tremor is one of the dominating symptoms of Parkinson’s disease (PD), which significantly limits activities of daily living. Along with medications, wearable devices have been proposed to suppress tremor. However, suppressing tremor without interfering with voluntary motion remains challenging and improvements are needed. The main goal of this work was to design algorithms for the automatic identification of the tremor type and voluntary motions, using only surface electromyography (sEMG) data. Towards this goal, a bidirectional long short-term memory (BiLSTM) algorithm was implemented that uses sEMG data to identify the motion and tremor type of people living with PD when performing a task. Moreover, in order to automate the training process, hyperparamter selection was performed using a regularized evolutionary algorithm. The results show that the accuracy of task classification among 15 people living with PD was , and the accuracy of tremor classification was . Both models performed significantly above chance levels (20% and 33% for task and tremor classification, respectively). Thus, it was concluded that the trained models, based on using purely sEMG signals, could successfully identify the task and tremor types.
2 September 2024 in IEEE Transactions on Neural Systems and Rehabilitation Engineering
Parkinson’s disease (PD) and essential tremor are two major causes of pathological tremor among people over 60 years old. Due to the side effects and complications of traditional tremor management methods such as medication and deep brain surgery, non invasive tremor suppression methods have become more popular in recent years. Functional electrical stimulation (FES) is one of the methods used to reduce tremor in several studies. However, the effect of different FES parameters on tremor suppression and discomfort level, including amplitude, the number of pulses in each stimulation burst, frequency, and pulse width is yet to be studied for longer stimulation durations. Therefore, in this work, experiments were performed on 14 participants with PD to evaluate the effect of thirty seconds of out-of-phase electrical stimulation on wrist tremor at rest. Trials were conducted by varying the stimulation amplitude and the number of pulses while keeping the frequency and pulse width constant. Each test was repeated three times for each participant. The results showed an overall tremor suppression for 11 out of 14 participants and no average positive effects for three participants. It is concluded that despite the effectiveness of FES in tremor suppression, each set of FES parameters showed different suppression levels among participants due to the variability of tremor over time. Thus, for this method to be effective, an adaptive control system would be required to tune FES parameters in real time according to changes in tremor during extended stimulation periods.
18 September 2023 in IEEE Robotics and Automation Letters
Wearable technologies have shown promising results in tremor management, making them a feasible alternative to current treatments. Devices based on active actuation, such as electric motors, show high tremor suppression rate, but are heavy and bulky. In contrast, devices based on functional electrical stimulation (FES) are lightweight and smaller in size, but might cause pain, discomfort, and FES-induced muscle fatigue. Also, when the stimulation parameters do not adapt to the tremor, their suppression performance is compromised. Therefore, a multimodal approach was developed and tested by modeling wrist joint dynamics and simulating the muscle response to FES based on an existing dataset collected from 18 participants with Parkinson's disease. The goal was to evaluate and compare the performance of a multimodal device to that of an FES-only or an electric-motor-only approach. A nonlinear control system allocates the control effort between FES and motor torque based on the tremor level. Results showed an improvement in tremor suppression level (up to 12%) in the multimodal approach compared to FES only when there is voluntary motion. Also, the voluntary motion tracking error was lower in the multimodal approach, compared to the FES-only method (up to 57%). No notable improvement in tremor suppression level or voluntary motion tracking error was observed by comparing the multimodal system and the motor only approach. However, the advantage of using a multimodal system compared to the motor-only system is the reduction of the required motor torque resulting in reduced weight and size of the final device.